Induction of breast cancer resistance protein by the camptothecin derivative DX-8951f is associated with minor reduction of antitumour activity View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2002-09

AUTHORS

A H van Hattum, E Boven, G Kohlhagen, G L Scheffer, H M M Schlüper, H M Pinedo, I J Hoogsteen, M Maliepaard, R J Scheper, Y Pommier

ABSTRACT

DX-8951f (exatecan mesylate), a new water-soluble derivative of camptothecin, is currently being evaluated in phase II clinical trials. Resistance may be acquired when treating cancer patients with DX-8951f. Therefore, we selected a subline of the human ovarian cancer cell line A2780 for resistance against DX-8951f to investigate possible mechanisms of resistance. This DX-8951f-resistant subline, designated 2780DX8 (resistance factor=9.3), displayed a typical cross-resistance pattern including compounds, such as topotecan (resistance factor =34), SN-38 (resistance factor =47), mitoxantrone (resistance factor =59) and doxorubicin (resistance factor =2.9), which have previously been associated with the expression of breast cancer resistance protein. 2780DX8 cells did not show changes in the topoisomerase I gene, in topoisomerase I protein levels or catalytic activity. Overexpression of breast cancer resistance protein could be detected, both at the mRNA and protein level, while staining for Pgp, MRP1, or LRP was negative. GF120918, an inhibitor of breast cancer resistance protein, was able to reverse the DX-8951f-induced resistance in 2780DX8 cells. In vivo experiments in well-established 2780DX8 human tumour xenografts demonstrated that the growth inhibition induced by CPT-11 was more affected by breast cancer resistance protein expression than that of DX-8951f. These data indicate for the first time that DX-8951f is able to induce breast cancer resistance protein as a mechanism of resistance. Breast cancer resistance protein, however, results in only minor reduction of antitumour activity of DX-8951f which is an advantage over topotecan and CPT-11/SN-38. More... »

PAGES

665

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.bjc.6600508

DOI

http://dx.doi.org/10.1038/sj.bjc.6600508

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1009894683

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/12237778


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "ATP Binding Cassette Transporter, Subfamily B, Member 1", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "ATP Binding Cassette Transporter, Subfamily G, Member 2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "ATP-Binding Cassette Transporters", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Acridines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antigens, CD", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents, Phytogenic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Breast Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Camptothecin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Division", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA Topoisomerases, Type I", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Resistance, Neoplasm", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunoenzyme Techniques", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Isoquinolines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Membrane Glycoproteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice, Nude", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mutation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasms, Experimental", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ovarian Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tetrahydroisoquinolines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tetraspanin 29", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tetrazolium Salts", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thiazoles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Topoisomerase I Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Cells, Cultured", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "VU University Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.16872.3a", 
          "name": [
            "Department of Medical Oncology, Vrije Universiteit Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "van Hattum", 
        "givenName": "A H", 
        "id": "sg:person.01370321533.99", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01370321533.99"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "VU University Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.16872.3a", 
          "name": [
            "Department of Medical Oncology, Vrije Universiteit Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Boven", 
        "givenName": "E", 
        "id": "sg:person.013145274244.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013145274244.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Institute of Arthritis and Musculoskeletal and Skin Diseases", 
          "id": "https://www.grid.ac/institutes/grid.420086.8", 
          "name": [
            "Laboratory of Molecular Pharmacology, National Cancer Institute, NIH, Bethesda, Maryland, MD 20892, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kohlhagen", 
        "givenName": "G", 
        "id": "sg:person.01135271412.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01135271412.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "VU University Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.16872.3a", 
          "name": [
            "Department of Pathology, Vrije Universiteit Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Scheffer", 
        "givenName": "G L", 
        "id": "sg:person.0640464532.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0640464532.50"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "VU University Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.16872.3a", 
          "name": [
            "Department of Medical Oncology, Vrije Universiteit Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schl\u00fcper", 
        "givenName": "H M M", 
        "id": "sg:person.01347413605.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01347413605.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "VU University Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.16872.3a", 
          "name": [
            "Department of Medical Oncology, Vrije Universiteit Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pinedo", 
        "givenName": "H M", 
        "id": "sg:person.013437631522.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013437631522.70"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "VU University Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.16872.3a", 
          "name": [
            "Department of Medical Oncology, Vrije Universiteit Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hoogsteen", 
        "givenName": "I J", 
        "id": "sg:person.0670034035.60", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0670034035.60"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Antoni van Leeuwenhoek Hospital", 
          "id": "https://www.grid.ac/institutes/grid.430814.a", 
          "name": [
            "Division of Experimental Therapy, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Maliepaard", 
        "givenName": "M", 
        "id": "sg:person.01116164660.61", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116164660.61"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "VU University Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.16872.3a", 
          "name": [
            "Department of Pathology, Vrije Universiteit Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Scheper", 
        "givenName": "R J", 
        "id": "sg:person.015343123504.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015343123504.30"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Institute of Arthritis and Musculoskeletal and Skin Diseases", 
          "id": "https://www.grid.ac/institutes/grid.420086.8", 
          "name": [
            "Laboratory of Molecular Pharmacology, National Cancer Institute, NIH, Bethesda, Maryland, MD 20892, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pommier", 
        "givenName": "Y", 
        "id": "sg:person.01357705235.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01357705235.00"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf00689205", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000550796", 
          "https://doi.org/10.1007/bf00689205"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00689205", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000550796", 
          "https://doi.org/10.1007/bf00689205"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.95.26.15665", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000554577"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00001813-200006000-00005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009178814"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00001813-200006000-00005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009178814"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.78.6.3487", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010644979"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0167-4781(95)00029-g", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011142448"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1146/annurev.pharmtox.39.1.361", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018001845"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0304-3835(99)00182-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018329371"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0304-3835(99)00182-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018329371"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1054/drup.1999.0102", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024306881"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00001813-199808000-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028803170"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00001813-199808000-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028803170"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/91.5.429", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029235370"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0006-2952(00)00396-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033927071"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1998.427", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039007798", 
          "https://doi.org/10.1038/bjc.1998.427"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1998.427", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039007798", 
          "https://doi.org/10.1038/bjc.1998.427"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1349-7006.1995.tb02468.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042509284"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1349-7006.1995.tb02468.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042509284"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1998.1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046474258", 
          "https://doi.org/10.1038/bjc.1998.1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1998.1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046474258", 
          "https://doi.org/10.1038/bjc.1998.1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0165-6147(90)90008-v", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047250011"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0165-6147(90)90008-v", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047250011"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s002800050807", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050431011", 
          "https://doi.org/10.1007/s002800050807"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1349-7006.1997.tb00448.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050639521"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1349-7006.1997.tb00448.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050639521"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/(sici)1097-0215(19971210)73:6<891::aid-ijc22>3.0.co;2-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053242244"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074523665", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074565827", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074644500", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074666197", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074673370", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074801145", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074801181", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082456525", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082791809", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083360547", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083376126", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2002-09", 
    "datePublishedReg": "2002-09-01", 
    "description": "DX-8951f (exatecan mesylate), a new water-soluble derivative of camptothecin, is currently being evaluated in phase II clinical trials. Resistance may be acquired when treating cancer patients with DX-8951f. Therefore, we selected a subline of the human ovarian cancer cell line A2780 for resistance against DX-8951f to investigate possible mechanisms of resistance. This DX-8951f-resistant subline, designated 2780DX8 (resistance factor=9.3), displayed a typical cross-resistance pattern including compounds, such as topotecan (resistance factor =34), SN-38 (resistance factor =47), mitoxantrone (resistance factor =59) and doxorubicin (resistance factor =2.9), which have previously been associated with the expression of breast cancer resistance protein. 2780DX8 cells did not show changes in the topoisomerase I gene, in topoisomerase I protein levels or catalytic activity. Overexpression of breast cancer resistance protein could be detected, both at the mRNA and protein level, while staining for Pgp, MRP1, or LRP was negative. GF120918, an inhibitor of breast cancer resistance protein, was able to reverse the DX-8951f-induced resistance in 2780DX8 cells. In vivo experiments in well-established 2780DX8 human tumour xenografts demonstrated that the growth inhibition induced by CPT-11 was more affected by breast cancer resistance protein expression than that of DX-8951f. These data indicate for the first time that DX-8951f is able to induce breast cancer resistance protein as a mechanism of resistance. Breast cancer resistance protein, however, results in only minor reduction of antitumour activity of DX-8951f which is an advantage over topotecan and CPT-11/SN-38.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/sj.bjc.6600508", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "6", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "87"
      }
    ], 
    "name": "Induction of breast cancer resistance protein by the camptothecin derivative DX-8951f is associated with minor reduction of antitumour activity", 
    "pagination": "665", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "2f232231c5cc2fd80b8dc0528e153ac7cd466fed9dbd9a13cc123158f27d3172"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "12237778"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0370635"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.bjc.6600508"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1009894683"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.bjc.6600508", 
      "https://app.dimensions.ai/details/publication/pub.1009894683"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T12:16", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000361_0000000361/records_54017_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/6600508"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6600508'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6600508'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6600508'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6600508'


 

This table displays all metadata directly associated to this object as RDF triples.

335 TRIPLES      21 PREDICATES      87 URIs      50 LITERALS      38 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.bjc.6600508 schema:about N09eb430f27164384a7fcacdf2ef651a5
2 N147cad94133f40b2866d0495e254e658
3 N17dce10476f9476583f615777f9e2ff0
4 N1cc0558f51424bc2b8b6b01db1083af3
5 N26ea11d9d61d42fa8750a94b835ead18
6 N3a219ab0a4ae43758cd04baea95564c9
7 N3adbacc19c894f80aa20d7f72ada5554
8 N3e128c3e41df4245a84254f044373388
9 N43cf8518afce4b0ea4359c5f269e3187
10 N4803d64858d24070b496989749938637
11 N497172aa983d408ca65f3fd4e1eab9e6
12 N49c0448185e84990992736de076138e0
13 N5f4faf805b134b5b8d6128a685ebe3ce
14 N608a87957d024dff8f591c044d1c2da4
15 N61b4133fab474e949e1cc8ceccef556c
16 N6b5a9aeb345d43e99545f62981882ac4
17 N88414175f4dd411b8ff7c35695b1724d
18 N8acac1396b804464a9485548730564ab
19 N9e673468c8b44f038f04a0b269cf7057
20 N9fdbbd2c54dc45e29db4fe0aa85bba2f
21 Nafd21451aa474894bdbf45fb33b3fa84
22 Nb0d5895a6c9840659890c5a29f3e51bc
23 Nb3c32a873b9d4bb294130090821ffea7
24 Nd441ac7109b74302a63054e7e6e5ae7a
25 Nd479a3f107e845cf85fd24bd79629d01
26 Neb1fef84ac8f4e4a8b75a843fd46f783
27 Nefa724672d954a9f970358b72fbdc291
28 Nf2d3f16a2e3a44c18cad3b2b34ac58a8
29 Nf940297de3b04795981b752918b547d6
30 anzsrc-for:11
31 anzsrc-for:1112
32 schema:author Nde10f209ff1d4843b0299d2fd82749ea
33 schema:citation sg:pub.10.1007/bf00689205
34 sg:pub.10.1007/s002800050807
35 sg:pub.10.1038/bjc.1998.1
36 sg:pub.10.1038/bjc.1998.427
37 https://app.dimensions.ai/details/publication/pub.1074523665
38 https://app.dimensions.ai/details/publication/pub.1074565827
39 https://app.dimensions.ai/details/publication/pub.1074644500
40 https://app.dimensions.ai/details/publication/pub.1074666197
41 https://app.dimensions.ai/details/publication/pub.1074673370
42 https://app.dimensions.ai/details/publication/pub.1074801145
43 https://app.dimensions.ai/details/publication/pub.1074801181
44 https://app.dimensions.ai/details/publication/pub.1082456525
45 https://app.dimensions.ai/details/publication/pub.1082791809
46 https://app.dimensions.ai/details/publication/pub.1083360547
47 https://app.dimensions.ai/details/publication/pub.1083376126
48 https://doi.org/10.1002/(sici)1097-0215(19971210)73:6<891::aid-ijc22>3.0.co;2-6
49 https://doi.org/10.1016/0165-6147(90)90008-v
50 https://doi.org/10.1016/0167-4781(95)00029-g
51 https://doi.org/10.1016/s0006-2952(00)00396-8
52 https://doi.org/10.1016/s0304-3835(99)00182-2
53 https://doi.org/10.1054/drup.1999.0102
54 https://doi.org/10.1073/pnas.78.6.3487
55 https://doi.org/10.1073/pnas.95.26.15665
56 https://doi.org/10.1093/jnci/91.5.429
57 https://doi.org/10.1097/00001813-199808000-00002
58 https://doi.org/10.1097/00001813-200006000-00005
59 https://doi.org/10.1111/j.1349-7006.1995.tb02468.x
60 https://doi.org/10.1111/j.1349-7006.1997.tb00448.x
61 https://doi.org/10.1146/annurev.pharmtox.39.1.361
62 schema:datePublished 2002-09
63 schema:datePublishedReg 2002-09-01
64 schema:description DX-8951f (exatecan mesylate), a new water-soluble derivative of camptothecin, is currently being evaluated in phase II clinical trials. Resistance may be acquired when treating cancer patients with DX-8951f. Therefore, we selected a subline of the human ovarian cancer cell line A2780 for resistance against DX-8951f to investigate possible mechanisms of resistance. This DX-8951f-resistant subline, designated 2780DX8 (resistance factor=9.3), displayed a typical cross-resistance pattern including compounds, such as topotecan (resistance factor =34), SN-38 (resistance factor =47), mitoxantrone (resistance factor =59) and doxorubicin (resistance factor =2.9), which have previously been associated with the expression of breast cancer resistance protein. 2780DX8 cells did not show changes in the topoisomerase I gene, in topoisomerase I protein levels or catalytic activity. Overexpression of breast cancer resistance protein could be detected, both at the mRNA and protein level, while staining for Pgp, MRP1, or LRP was negative. GF120918, an inhibitor of breast cancer resistance protein, was able to reverse the DX-8951f-induced resistance in 2780DX8 cells. In vivo experiments in well-established 2780DX8 human tumour xenografts demonstrated that the growth inhibition induced by CPT-11 was more affected by breast cancer resistance protein expression than that of DX-8951f. These data indicate for the first time that DX-8951f is able to induce breast cancer resistance protein as a mechanism of resistance. Breast cancer resistance protein, however, results in only minor reduction of antitumour activity of DX-8951f which is an advantage over topotecan and CPT-11/SN-38.
65 schema:genre research_article
66 schema:inLanguage en
67 schema:isAccessibleForFree true
68 schema:isPartOf N4fc79192cf9c49a3a0a1aac43dedc53a
69 N5f5e9d9191b847fcae55c95d267810c3
70 sg:journal.1017082
71 schema:name Induction of breast cancer resistance protein by the camptothecin derivative DX-8951f is associated with minor reduction of antitumour activity
72 schema:pagination 665
73 schema:productId N0e613842d5db4993b0bcc4b00079a8cd
74 N1b0f63031b014df58972e9cd54ea881a
75 N3dfb72850d8a4ef685aea8df52cd08bd
76 N73315216cdae46e5b02099962bfff502
77 Ne7f78c27802c4d78b07fafa359a73518
78 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009894683
79 https://doi.org/10.1038/sj.bjc.6600508
80 schema:sdDatePublished 2019-04-11T12:16
81 schema:sdLicense https://scigraph.springernature.com/explorer/license/
82 schema:sdPublisher N243bd866dc014e0da3ead5ef76e2519e
83 schema:url https://www.nature.com/articles/6600508
84 sgo:license sg:explorer/license/
85 sgo:sdDataset articles
86 rdf:type schema:ScholarlyArticle
87 N01e8295f518b4f1b9db3f249a0845e9d rdf:first sg:person.015343123504.30
88 rdf:rest Nf732d79b7e7a482f8c046bef9464b5ba
89 N09eb430f27164384a7fcacdf2ef651a5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Topoisomerase I Inhibitors
91 rdf:type schema:DefinedTerm
92 N0e613842d5db4993b0bcc4b00079a8cd schema:name pubmed_id
93 schema:value 12237778
94 rdf:type schema:PropertyValue
95 N147cad94133f40b2866d0495e254e658 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Antineoplastic Agents, Phytogenic
97 rdf:type schema:DefinedTerm
98 N17dce10476f9476583f615777f9e2ff0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Acridines
100 rdf:type schema:DefinedTerm
101 N1b0f63031b014df58972e9cd54ea881a schema:name readcube_id
102 schema:value 2f232231c5cc2fd80b8dc0528e153ac7cd466fed9dbd9a13cc123158f27d3172
103 rdf:type schema:PropertyValue
104 N1c07d7e2ff9045478be260d311da40a7 rdf:first sg:person.0670034035.60
105 rdf:rest N514c22edad4a4d80bcd55f7f30bcc5d5
106 N1cc0558f51424bc2b8b6b01db1083af3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Humans
108 rdf:type schema:DefinedTerm
109 N243bd866dc014e0da3ead5ef76e2519e schema:name Springer Nature - SN SciGraph project
110 rdf:type schema:Organization
111 N26ea11d9d61d42fa8750a94b835ead18 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name ATP-Binding Cassette Transporters
113 rdf:type schema:DefinedTerm
114 N3a219ab0a4ae43758cd04baea95564c9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Mutation
116 rdf:type schema:DefinedTerm
117 N3adbacc19c894f80aa20d7f72ada5554 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Thiazoles
119 rdf:type schema:DefinedTerm
120 N3dfb72850d8a4ef685aea8df52cd08bd schema:name dimensions_id
121 schema:value pub.1009894683
122 rdf:type schema:PropertyValue
123 N3e128c3e41df4245a84254f044373388 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name ATP Binding Cassette Transporter, Subfamily G, Member 2
125 rdf:type schema:DefinedTerm
126 N43cf8518afce4b0ea4359c5f269e3187 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Tetrazolium Salts
128 rdf:type schema:DefinedTerm
129 N4803d64858d24070b496989749938637 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Tetraspanin 29
131 rdf:type schema:DefinedTerm
132 N497172aa983d408ca65f3fd4e1eab9e6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Tetrahydroisoquinolines
134 rdf:type schema:DefinedTerm
135 N49c0448185e84990992736de076138e0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Female
137 rdf:type schema:DefinedTerm
138 N4fc79192cf9c49a3a0a1aac43dedc53a schema:volumeNumber 87
139 rdf:type schema:PublicationVolume
140 N514c22edad4a4d80bcd55f7f30bcc5d5 rdf:first sg:person.01116164660.61
141 rdf:rest N01e8295f518b4f1b9db3f249a0845e9d
142 N5f4faf805b134b5b8d6128a685ebe3ce schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Camptothecin
144 rdf:type schema:DefinedTerm
145 N5f5e9d9191b847fcae55c95d267810c3 schema:issueNumber 6
146 rdf:type schema:PublicationIssue
147 N608a87957d024dff8f591c044d1c2da4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Antigens, CD
149 rdf:type schema:DefinedTerm
150 N61b4133fab474e949e1cc8ceccef556c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Mice
152 rdf:type schema:DefinedTerm
153 N6b5a9aeb345d43e99545f62981882ac4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Mice, Nude
155 rdf:type schema:DefinedTerm
156 N73315216cdae46e5b02099962bfff502 schema:name doi
157 schema:value 10.1038/sj.bjc.6600508
158 rdf:type schema:PropertyValue
159 N7344a1c4f92448889a81a8e5501b3dea rdf:first sg:person.013437631522.70
160 rdf:rest N1c07d7e2ff9045478be260d311da40a7
161 N774879547299494f8d4aa76f265ee135 rdf:first sg:person.013145274244.39
162 rdf:rest Nf33bf174c5dd48de91caa039cffbe651
163 N88414175f4dd411b8ff7c35695b1724d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Animals
165 rdf:type schema:DefinedTerm
166 N8acac1396b804464a9485548730564ab schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Cell Division
168 rdf:type schema:DefinedTerm
169 N9e673468c8b44f038f04a0b269cf7057 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Ovarian Neoplasms
171 rdf:type schema:DefinedTerm
172 N9fdbbd2c54dc45e29db4fe0aa85bba2f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Neoplasms, Experimental
174 rdf:type schema:DefinedTerm
175 Nafd21451aa474894bdbf45fb33b3fa84 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Drug Resistance, Neoplasm
177 rdf:type schema:DefinedTerm
178 Nb0d5895a6c9840659890c5a29f3e51bc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Membrane Glycoproteins
180 rdf:type schema:DefinedTerm
181 Nb3c32a873b9d4bb294130090821ffea7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name ATP Binding Cassette Transporter, Subfamily B, Member 1
183 rdf:type schema:DefinedTerm
184 Nc199b2df1a004b478eedc211337bb6a7 rdf:first sg:person.01347413605.66
185 rdf:rest N7344a1c4f92448889a81a8e5501b3dea
186 Nd441ac7109b74302a63054e7e6e5ae7a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name DNA Topoisomerases, Type I
188 rdf:type schema:DefinedTerm
189 Nd479a3f107e845cf85fd24bd79629d01 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Breast Neoplasms
191 rdf:type schema:DefinedTerm
192 Nd9879642780d4043a129dbd07a67d1ff rdf:first sg:person.0640464532.50
193 rdf:rest Nc199b2df1a004b478eedc211337bb6a7
194 Nde10f209ff1d4843b0299d2fd82749ea rdf:first sg:person.01370321533.99
195 rdf:rest N774879547299494f8d4aa76f265ee135
196 Ne7f78c27802c4d78b07fafa359a73518 schema:name nlm_unique_id
197 schema:value 0370635
198 rdf:type schema:PropertyValue
199 Neb1fef84ac8f4e4a8b75a843fd46f783 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
200 schema:name Immunoenzyme Techniques
201 rdf:type schema:DefinedTerm
202 Nefa724672d954a9f970358b72fbdc291 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
203 schema:name Tumor Cells, Cultured
204 rdf:type schema:DefinedTerm
205 Nf2d3f16a2e3a44c18cad3b2b34ac58a8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
206 schema:name Neoplasm Proteins
207 rdf:type schema:DefinedTerm
208 Nf33bf174c5dd48de91caa039cffbe651 rdf:first sg:person.01135271412.10
209 rdf:rest Nd9879642780d4043a129dbd07a67d1ff
210 Nf732d79b7e7a482f8c046bef9464b5ba rdf:first sg:person.01357705235.00
211 rdf:rest rdf:nil
212 Nf940297de3b04795981b752918b547d6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
213 schema:name Isoquinolines
214 rdf:type schema:DefinedTerm
215 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
216 schema:name Medical and Health Sciences
217 rdf:type schema:DefinedTerm
218 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
219 schema:name Oncology and Carcinogenesis
220 rdf:type schema:DefinedTerm
221 sg:journal.1017082 schema:issn 0007-0920
222 1532-1827
223 schema:name British Journal of Cancer
224 rdf:type schema:Periodical
225 sg:person.01116164660.61 schema:affiliation https://www.grid.ac/institutes/grid.430814.a
226 schema:familyName Maliepaard
227 schema:givenName M
228 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116164660.61
229 rdf:type schema:Person
230 sg:person.01135271412.10 schema:affiliation https://www.grid.ac/institutes/grid.420086.8
231 schema:familyName Kohlhagen
232 schema:givenName G
233 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01135271412.10
234 rdf:type schema:Person
235 sg:person.013145274244.39 schema:affiliation https://www.grid.ac/institutes/grid.16872.3a
236 schema:familyName Boven
237 schema:givenName E
238 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013145274244.39
239 rdf:type schema:Person
240 sg:person.013437631522.70 schema:affiliation https://www.grid.ac/institutes/grid.16872.3a
241 schema:familyName Pinedo
242 schema:givenName H M
243 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013437631522.70
244 rdf:type schema:Person
245 sg:person.01347413605.66 schema:affiliation https://www.grid.ac/institutes/grid.16872.3a
246 schema:familyName Schlüper
247 schema:givenName H M M
248 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01347413605.66
249 rdf:type schema:Person
250 sg:person.01357705235.00 schema:affiliation https://www.grid.ac/institutes/grid.420086.8
251 schema:familyName Pommier
252 schema:givenName Y
253 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01357705235.00
254 rdf:type schema:Person
255 sg:person.01370321533.99 schema:affiliation https://www.grid.ac/institutes/grid.16872.3a
256 schema:familyName van Hattum
257 schema:givenName A H
258 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01370321533.99
259 rdf:type schema:Person
260 sg:person.015343123504.30 schema:affiliation https://www.grid.ac/institutes/grid.16872.3a
261 schema:familyName Scheper
262 schema:givenName R J
263 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015343123504.30
264 rdf:type schema:Person
265 sg:person.0640464532.50 schema:affiliation https://www.grid.ac/institutes/grid.16872.3a
266 schema:familyName Scheffer
267 schema:givenName G L
268 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0640464532.50
269 rdf:type schema:Person
270 sg:person.0670034035.60 schema:affiliation https://www.grid.ac/institutes/grid.16872.3a
271 schema:familyName Hoogsteen
272 schema:givenName I J
273 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0670034035.60
274 rdf:type schema:Person
275 sg:pub.10.1007/bf00689205 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000550796
276 https://doi.org/10.1007/bf00689205
277 rdf:type schema:CreativeWork
278 sg:pub.10.1007/s002800050807 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050431011
279 https://doi.org/10.1007/s002800050807
280 rdf:type schema:CreativeWork
281 sg:pub.10.1038/bjc.1998.1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046474258
282 https://doi.org/10.1038/bjc.1998.1
283 rdf:type schema:CreativeWork
284 sg:pub.10.1038/bjc.1998.427 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039007798
285 https://doi.org/10.1038/bjc.1998.427
286 rdf:type schema:CreativeWork
287 https://app.dimensions.ai/details/publication/pub.1074523665 schema:CreativeWork
288 https://app.dimensions.ai/details/publication/pub.1074565827 schema:CreativeWork
289 https://app.dimensions.ai/details/publication/pub.1074644500 schema:CreativeWork
290 https://app.dimensions.ai/details/publication/pub.1074666197 schema:CreativeWork
291 https://app.dimensions.ai/details/publication/pub.1074673370 schema:CreativeWork
292 https://app.dimensions.ai/details/publication/pub.1074801145 schema:CreativeWork
293 https://app.dimensions.ai/details/publication/pub.1074801181 schema:CreativeWork
294 https://app.dimensions.ai/details/publication/pub.1082456525 schema:CreativeWork
295 https://app.dimensions.ai/details/publication/pub.1082791809 schema:CreativeWork
296 https://app.dimensions.ai/details/publication/pub.1083360547 schema:CreativeWork
297 https://app.dimensions.ai/details/publication/pub.1083376126 schema:CreativeWork
298 https://doi.org/10.1002/(sici)1097-0215(19971210)73:6<891::aid-ijc22>3.0.co;2-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053242244
299 rdf:type schema:CreativeWork
300 https://doi.org/10.1016/0165-6147(90)90008-v schema:sameAs https://app.dimensions.ai/details/publication/pub.1047250011
301 rdf:type schema:CreativeWork
302 https://doi.org/10.1016/0167-4781(95)00029-g schema:sameAs https://app.dimensions.ai/details/publication/pub.1011142448
303 rdf:type schema:CreativeWork
304 https://doi.org/10.1016/s0006-2952(00)00396-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033927071
305 rdf:type schema:CreativeWork
306 https://doi.org/10.1016/s0304-3835(99)00182-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018329371
307 rdf:type schema:CreativeWork
308 https://doi.org/10.1054/drup.1999.0102 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024306881
309 rdf:type schema:CreativeWork
310 https://doi.org/10.1073/pnas.78.6.3487 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010644979
311 rdf:type schema:CreativeWork
312 https://doi.org/10.1073/pnas.95.26.15665 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000554577
313 rdf:type schema:CreativeWork
314 https://doi.org/10.1093/jnci/91.5.429 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029235370
315 rdf:type schema:CreativeWork
316 https://doi.org/10.1097/00001813-199808000-00002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028803170
317 rdf:type schema:CreativeWork
318 https://doi.org/10.1097/00001813-200006000-00005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009178814
319 rdf:type schema:CreativeWork
320 https://doi.org/10.1111/j.1349-7006.1995.tb02468.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1042509284
321 rdf:type schema:CreativeWork
322 https://doi.org/10.1111/j.1349-7006.1997.tb00448.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1050639521
323 rdf:type schema:CreativeWork
324 https://doi.org/10.1146/annurev.pharmtox.39.1.361 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018001845
325 rdf:type schema:CreativeWork
326 https://www.grid.ac/institutes/grid.16872.3a schema:alternateName VU University Medical Center
327 schema:name Department of Medical Oncology, Vrije Universiteit Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands
328 Department of Pathology, Vrije Universiteit Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands
329 rdf:type schema:Organization
330 https://www.grid.ac/institutes/grid.420086.8 schema:alternateName National Institute of Arthritis and Musculoskeletal and Skin Diseases
331 schema:name Laboratory of Molecular Pharmacology, National Cancer Institute, NIH, Bethesda, Maryland, MD 20892, USA
332 rdf:type schema:Organization
333 https://www.grid.ac/institutes/grid.430814.a schema:alternateName Antoni van Leeuwenhoek Hospital
334 schema:name Division of Experimental Therapy, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
335 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...